Opendata, web and dolomites

PneumoCaTChER SIGNED

The role of cell-to-cell variability in pneumococcal virulence and antibiotic resistance

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PneumoCaTChER project word cloud

Explore the words cloud of the PneumoCaTChER project. It provides you a very rough idea of what is the project "PneumoCaTChER" about.

cycle    platforms    variability    pathogen    lung    pathogens    dual    within    pressure    outcome    grow    heterogeneity    microbe    underlying    phenotype    biology    originate    immune    collaborations    cellular    pneumococcal    bacterial    hypothesis    combining    influences    exploited    screening    noise    versa    pathogenic    perform    variation    unclear    imaging    opportunistic    populations    environment    excellent    though    genetic    infections    microfluidics    models    pneumococci    position    seq    epithelial    engineering    exhibit    reveal    host    setup    insights    single    rates    infection    helps    resistance    quantitative    pneumoniae    molecular    vice    mechanisms    driving    therapy    bacteria    cell    crispri    clonal    rna    switches    elude    transcriptomics    engineered    resist    overview    places    diverse    cells    poorly    antibiotic    strategies    bistable    synthetic    treatment    virulence    human    combined    streptococcus    innovative    sources    expression    phenotypic    gene   

Project "PneumoCaTChER" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITE DE LAUSANNE 

Organization address
address: Quartier Unil-Centre Bâtiment Unicentre
city: LAUSANNE
postcode: 1015
website: www.unil.ch

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Total cost 1˙999˙735 €
 EC max contribution 1˙999˙735 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-COG
 Funding Scheme ERC-COG
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2023-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITE DE LAUSANNE CH (LAUSANNE) coordinator 1˙999˙735.00

Map

 Project objective

Within clonal bacterial populations not all cells exhibit the same phenotype, even though they grow in the same environment. The molecular sources contributing to phenotypic variation are diverse and can originate from noise in gene expression to heterogeneity in growth rates or cell cycle state. Phenotypic variation helps pathogenic bacteria to elude the host immune response or resist antibiotic pressure. Vice versa, there is cell-to-cell variability in the host’s response towards pathogens that can be exploited by bacteria. How the combined cellular heterogeneity of both host and microbe contribute to infection outcome is poorly understood. The role of phenotypic variation on antibiotic resistance development is also unclear.

Recently, we developed novel single cell imaging systems as well as genetic engineering and screening platforms for application to the important opportunistic human pathogen Streptococcus pneumoniae. In addition, we generated a dual-transcriptomics overview of pneumococcal infection of human lung epithelial cells and setup collaborations to perform several infection models. This now places us in an excellent position to investigate the mechanisms and the importance of single cell behaviour for pneumococcal virulence and antibiotic resistance.

The driving hypothesis of this application is that the combined heterogeneity of host cells and pneumococci influences infection and antibiotic therapy outcome. To test this, we will use innovative approaches for infection biology by combining synthetic biology and quantitative single cell biology including single cell RNA-seq, CRISPRi, engineered bistable switches and microfluidics. We will reveal the molecular mechanisms underlying cell-to-cell variability and its importance in virulence and antibiotic resistance.

Insights obtained in this project will lead to a better understanding of phenotypic variation and might result in new treatment strategies for pneumococcal infections.

 Publications

year authors and title journal last update
List of publications.
2019 Jelle Slager, Rieza Aprianto, Jan-Willem Veening
Refining the Pneumococcal Competence Regulon by RNA Sequencing
published pages: , ISSN: 0021-9193, DOI: 10.1128/jb.00780-18
Journal of Bacteriology 201/13 2019-08-29
2019 Lance E. Keller, Anne-Stéphanie Rueff, Jun Kurushima, Jan-Willem Veening
Three New Integration Vectors and Fluorescent Proteins for Use in the Opportunistic Human Pathogen Streptococcus pneumoniae
published pages: 394, ISSN: 2073-4425, DOI: 10.3390/genes10050394
Genes 10/5 2019-08-29
2019 Chryslène Mercy, Adrien Ducret, Jelle Slager, Jean-Pierre Lavergne, Céline Freton, Sathya Narayanan Nagarajan, Pierre Simon Garcia, Marie-Francoise Noirot-Gros, Nelly Dubarry, Julien Nourikyan, Jan-Willem Veening, Christophe Grangeasse
RocS drives chromosome segregation and nucleoid protection in Streptococcus pneumoniae
published pages: , ISSN: 2058-5276, DOI: 10.1038/s41564-019-0472-z
Nature Microbiology 2019-08-29

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PNEUMOCATCHER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PNEUMOCATCHER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

KineTic (2020)

New Reagents for Quantifying the Routing and Kinetics of T-cell Activation

Read More  

E-DURA (2018)

Commercialization of novel soft neural interfaces

Read More  

NEUTRAMENTH (2018)

A redox-neutral process for the cost-efficient and environmentally friendly production of Menthol

Read More